{"filing":{"accession_number":"0001005286-26-000023","cik":"0001005286","ticker":"LFCR","company_name":"LIFECORE BIOMEDICAL, INC. \\DE\\","form":"8-K","filing_date":"2026-06-05","report_date":null,"primary_document":"lfcr-20260604.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528626000023/lfcr-20260604.htm"},"events":[{"id":3775,"run_id":3312,"accession_number":"0001005286-26-000023","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"LifeCore Biomedical held its Annual Meeting of Stockholders on June 4, 2026, with voting results on four proposals: election of nine directors, ratification of KPMG LLP as auditor, advisory approval of named executive officer compensation, and approval of the 2026 Stock Incentive Plan. All vote tallies (For, Against, Abstain, and Broker Non-Votes) are disclosed.","company_name":"LIFECORE BIOMEDICAL, INC. \\DE\\","ticker":"LFCR","filing_date":"2026-06-05","items":[{"id":4789,"accession_number":"0001005286-26-000023","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of the 2026 Stock Incentive Plan, a compensatory arrangement for officers and directors. The filing describes the plan's terms, share authorization (2.5 million shares plus rollovers from the 2019 Plan), and effective date. This is a material equity compensation plan approval, distinct from executive departures or appointments.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:12:19.712000+00:00","company_name":"","ticker":null,"filing_date":""},{"id":4790,"accession_number":"0001005286-26-000023","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of the Annual Meeting held on June 4, 2026. The filing presents voting outcomes for four proposals: election of nine directors (with detailed vote tallies for each nominee), ratification of KPMG LLP as auditor, advisory approval of named executive officer compensation, and approval of the 2026 Stock Incentive Plan. All results are presented with vote counts (For, Against, Abstain, and Broker Non-Votes where applicable), which is the standard format for shareholder vote result disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:12:19.712000+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4789,"accession_number":"0001005286-26-000023","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of the 2026 Stock Incentive Plan, a compensatory arrangement for officers and directors. The filing describes the plan's terms, share authorization (2.5 million shares plus rollovers from the 2019 Plan), and effective date. This is a material equity compensation plan approval, distinct from executive departures or appointments.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:12:19.712000+00:00","company_name":"LIFECORE BIOMEDICAL, INC. \\DE\\","ticker":"LFCR","filing_date":"2026-06-05"},{"id":4790,"accession_number":"0001005286-26-000023","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of the Annual Meeting held on June 4, 2026. The filing presents voting outcomes for four proposals: election of nine directors (with detailed vote tallies for each nominee), ratification of KPMG LLP as auditor, advisory approval of named executive officer compensation, and approval of the 2026 Stock Incentive Plan. All results are presented with vote counts (For, Against, Abstain, and Broker Non-Votes where applicable), which is the standard format for shareholder vote result disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:12:19.712000+00:00","company_name":"LIFECORE BIOMEDICAL, INC. \\DE\\","ticker":"LFCR","filing_date":"2026-06-05"}]}